MedPath

NATIONAL INSTITUTE ON DRUG ABUSE AND ADDICTION

πŸ‡΅πŸ‡°Pakistan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

391

Active:0
Completed:302

Trial Phases

6 Phases

Early Phase 1:3
Phase 1:109
Phase 2:129
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (315 trials with phase data)β€’ Click on a phase to view related trials

Phase 2
129 (41.0%)
Phase 1
109 (34.6%)
Not Applicable
42 (13.3%)
Phase 4
17 (5.4%)
Phase 3
15 (4.8%)
Early Phase 1
3 (1.0%)

Phase 1 Study of Oral MG001

Not Applicable
Not yet recruiting
Conditions
Safety and Tolerability in Healthy Subjects
Interventions
Drug: mitragynine
Drug: Placebo
First Posted Date
2025-10-02
Last Posted Date
2025-10-02
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
32
Registration Number
NCT07204171
Locations
πŸ‡ΊπŸ‡Έ

Altasciences Clinical Kansas, Overland Park, Kansas, United States

Causal Mechanisms of Odor-Guided Behavior in Humans

Not Applicable
Not yet recruiting
Conditions
Normal Physiology
First Posted Date
2025-08-01
Last Posted Date
2025-10-03
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
80
Registration Number
NCT07099092
Locations
πŸ‡ΊπŸ‡Έ

National Institute on Drug Abuse, Baltimore, Maryland, United States

Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl

Conditions
Substance Use Disorders (SUDs)
First Posted Date
2025-05-30
Last Posted Date
2025-10-03
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
30
Registration Number
NCT06995885
Locations
πŸ‡ΊπŸ‡Έ

National Institute on Drug Abuse, Baltimore, Maryland, United States

Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)

Phase 1
Recruiting
Conditions
Healthy Volunteers
First Posted Date
2025-03-11
Last Posted Date
2025-10-03
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
35
Registration Number
NCT06868914
Locations
πŸ‡ΊπŸ‡Έ

National Institute on Drug Abuse, Baltimore, Maryland, United States

Environment and Alcohol: A Pilot Study

Phase 1
Recruiting
Conditions
Alcohol Use Disorder
First Posted Date
2025-03-06
Last Posted Date
2025-10-03
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
44
Registration Number
NCT06860607
Locations
πŸ‡ΊπŸ‡Έ

National Institute on Drug Abuse, Baltimore, Maryland, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 79
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.